Latest immune response News

Institute for Glycomics awarded $2.66 million in NHMRC funding
NHMRC Ideas Grant to support development UniSA-Sementis peanut allergy vaccine
NHMRC Ideas Grants success
Heart and kidney disease research wins national funding
E-liquid flavour names cloud toxicity levels
Testing on patients begins for new experimental drug for sepsis
Australia secures 20 million extra Astra Zeneca vaccines for onshore manufacturing
Australia secures 20 million extra Astra Zeneca vaccines
Update on University of Queensland COVID-19 vaccine
Update on UQ COVID-19 vaccine
Discovery provides hope for early detection of serious COVID-19
Shedding light on sex differences in COVID-19 mortality
Differences in immunity and blood vessels likely protect children from severe COVID-19
Malaria and immunology researchers win Burnet Prize
When there is good vaccine news – efficacy is only beginning of story
Expert commentary: Oxford and AstraZeneca vaccine preliminary Phase III data
Nanobodies could hold clues to new COVID-19 therapies
Study to determine cyclosporine’s role in treating hospitalized COVID-19 patients
Sustained COVID-19 immunity promising for vaccine effectiveness
Study reveals immune cells’ COVID memory
Sydney to undertake clinical studies of needle-free vaccine patch
Monash researchers reveal COVID immunity lasts up to eight months, giving hope for long-term protection by vaccines
$41.7 million boost to commercialise lifesaving medical discoveries
WEHI director named 2020 Melburnian of Year
Department of Defense funds development of a new Lyme disease vaccine
Altered ‘coat’ disguises fatal brain virus from neutralizing antibodies
Trial of Oxford coronavirus vaccine in Southampton shows strong immune response in older adults
Arthritis drug effective in treating sickest COVID-19 patients
Houston companies awarded top honors at premier life science venture capital conference
Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India
Baylor COVID-19 vaccine begins clinical trial in India
Southampton Professor to lead Janssen COVID-19 vaccine trial
Drug research pivoted from prostate cancer to COVID-19 treatment
Seqirus will build world-class, next-generation $800m influenza vaccine manufacturing facility in Australia
Ludwig Lausanne receives Team Science Award from Society for Immunotherapy of Cancer
Light, liposomes, action: researchers show safer, more targeted way to deliver CRISPR gene therapy
Uracil Switch in SARS-CoV-2 Genome Alters Innate Immune Responses
HRI expands research into inflammation and blood pressure disorders
That’s a Wrap: Protein ‘Burritos’ Stabilize Vaccines
Could SARS-CoV-2 evolve resistance to COVID-19 vaccines?
A better test for tumor-targeting of CAR-T therapies
Australia Secures a further 50 Million Doses of COVID-19 Vaccine
Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
Teaming up: Coronavirus research at Cornell
Cancer treatment could be replicated for COVID-19
Australian research at centre of landmark treatment trial for COVID-19
‘Genome Archeologists’ at University and UHN activate immune response against cancer
Partial immunity and social distancing could reduce COVID-19 mortality rates